Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Total Liabilities : $68.14 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Integrated Diagnostics Holdings Total Liabilities?

Integrated Diagnostics Holdings's Total Liabilities for the quarter that ended in Mar. 2024 was $68.14 Mil.

Integrated Diagnostics Holdings's quarterly Total Liabilities increased from Jun. 2023 ($84.75 Mil) to Dec. 2023 ($86.36 Mil) but then declined from Dec. 2023 ($86.36 Mil) to Mar. 2024 ($68.14 Mil).

Integrated Diagnostics Holdings's annual Total Liabilities declined from Dec. 2021 ($219.08 Mil) to Dec. 2022 ($115.65 Mil) and declined from Dec. 2022 ($115.65 Mil) to Dec. 2023 ($86.36 Mil).

Integrated Diagnostics Holdings Total Liabilities Historical Data

The historical data trend for Integrated Diagnostics Holdings's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Total Liabilities Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

86.77

111.57

219.08

115.65

86.36

Integrated Diagnostics Holdings Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															115.65	88.56	84.75	86.36	68.14

Integrated Diagnostics Holdings Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Integrated Diagnostics Holdings's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	41.262	+	(31.018	+	14.082
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	86.36

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	186.675	-	100.313
	=	86.36

Integrated Diagnostics Holdings's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	34.886	+	(22.611	+	10.645
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	68.14

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	143.783	-	75.642
	=	68.14

Integrated Diagnostics Holdings Total Liabilities Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (OTCPK:IDGXF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

IDHCl:UK IDHC:UK IDHC.CA:Egypt 8I8:Germany

Address

12 Castle Street, Saint Helier, JEY, JE2 3RT

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider. It is a fully integrated diagnostics service provider operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segment- Contract Segment and Walk-in Segment. It derives majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings (Integrated Diagnostics Holdings) Headlines

From GuruFocus

Equity Portfolio as a Savings Account

By Steven CHEN • 09-24-2021